Xbrane Biopharma
0,156
SEK
-4,29 %
XBRANE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
8 investorer følger denne virksomhed
-4,29%
-27,27%
0%
-44,19%
-86,24%
-83,6%
-98,6%
-96,03%
-95,91%
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Læs mereMarkedsværdi
239,02 mio. SEK
Aktieomsætning
936,64 t SEK
Omsætning
238,73 mio.
EBIT %
-134,95 %
P/E
-
Udbytteafkast, %
-
Finanskalender
21.2
2025
Årsrapport '24
5.5
2025
Generalforsamling '24
8.5
2025
Delårsrapport Q1'25
ViserAlle indholdstyper
XBRANE BIOPHARMA'S PRINCIPAL OWNER SYSTEMATIC GROUP PROVIDES A SHORT-TERM LOAN OF SEK 20 M TO THE COMPANY
Xbrane AB (publ) today announces that the company's CFO, Anette Lindqvist, has announced her intention to retire and will leave her position during the spring of 2025.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools